Merck Serono Ventures
Merck Serono Ventures is a strategic, corporate venture capital fund that invests in emerging biotechnology companies. The fund invests in biotech start-up companies that have the potential to provide innovative products in Merck Serono’s core therapeutic areas, in particular in Neurodegenerative Diseases, Oncology, Autoimmune & Inflammatory Diseases, Endocrinology and Fertility.
In addition, Merck Serono Ventures invests in companies developing innovative technologies that could enable the discovery and development of new products in Merck Serono’s core therapeutic areas.
Milestones
Investments
| Company |
Date |
Round |
Size |
Participants |
| Anaphore | 6/09 | Series A | $13M | 5 |
| Ambrx | 4/09 | Series D | $10M | 7 |
Videos
Sources
-
Anaphore, Inc.: Series A $13M (onbiovc.com)
[edit]
-
Ambrx, Inc.: Series D $10M (onbiovc.com)
[edit]
